Inocucor, the Denver-based developer and producer of biological crop inputs, welcomes David Sisk as senior vice president of finance and administration and chief financial officer.
Sisk is an accomplished financial executive whose previous experience includes leadership roles in Armacell, Platform Specialty Products Corporation and Cheminova A/S. According to a news release, he is skilled in business strategy and process improvement, and guiding companies through mergers and acquisitions. He has a master’s in economics from North Carolina State University and is a certified public accountant.
“In the past year, Inocucor has moved from being an emerging startup to a growing commercial enterprise,” says Donald Marvin, Inocucor president and CEO. “This newest addition to our executive leadership team will help guide the company as we build our business throughout the Americas and into Western Europe. David is a well-credentialed financial executive with extensive international experience, including strategic M&A.”
Inocucor produces microbial products based on a patented fermentation process that help improve plant health and productivity. Its products are in use by growers in Canada and the United States. The company has raised more than $50 million in private equity funds in the past three years.
